help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernqvist-Forbes, E.
Right arrow Articles by Brismar, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernqvist-Forbes, E.
Right arrow Articles by Brismar, K.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 8 2677-2680
Copyright © 1997 by The Endocrine Society

Experimental Studies

Influence of Circulating Epinephrine and Norepinephrine on Insulin-Like Growth Factor Binding Protein-1 in Humans

Eva Fernqvist-Forbes, Agneta Hilding, Karin Ekberg and Kerstin Brismar

Department of Surgical Sciences, Division of Clinical Physiology (E.F-F., K.E.); and Department of Molecular Medicine, Endocrine and Diabetes Unit (A.H., K.B.) Karolinska Hospital, Stockholm, Sweden

Address all correspondence and requests for reprints to: Eva Fernqvist-Forbes, Division of Clinical Physiology, Karolinska Hospital, S-171 76 Stockholm, Sweden.

The aim of the present study was to investigate the influence of circulating epinephrine (Epi) and norepinephrine (Norepi) on serum insulin-like growth factor binding protein-1 (IGFBP-1) concentrations. Healthy men received 0.3 nmol·kg·min Epi iv (n = 6), 0.5 nmol·kg·min Norepi iv (n = 7), or saline (n = 5) during 30 min. Arterial blood samples were obtained before, during, and 120 min after infusion. During the catecholamine infusion arterial Epi and Norepi plasma concentrations reached 6.35 ± 0.53 and 15.65 ± 2.71 nmol/L, respectively, which resulted in significant increases in glucose concentrations. When Epi was infused, IGFBP-1 increased from 45 ± 6 µg/L to 76 ± 10 µg/L (P < 0.05) 60 min after the infusion. Epi was also followed by increases in insulin, C-peptide, and glucagon. Norepi resulted in a slight increase in circulating IGFBP-1 (43 ± 6 to 54 ± 8 nmol/L, NS). The findings suggest that Epi, at plasma concentrations similar to those reached during physical stress, stimulates the production of IGFBP-1 in humans.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
S B Catrina, R Rotarus, I R Botusan, M Coculescu, and K Brismar
Desmopressin increases IGF-binding protein-1 in humans.
Eur. J. Endocrinol., April 1, 2008; 158(4): 479 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Wallander, A. Norhammar, K. Malmberg, J. Ohrvik, L. Ryden, and K. Brismar
IGF Binding Protein 1 Predicts Cardiovascular Morbidity and Mortality in Patients With Acute Myocardial Infarction and Type 2 Diabetes
Diabetes Care, September 1, 2007; 30(9): 2343 - 2348.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. A. Frost, G. J. Nystrom, and C. H. Lang
Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E809 - E817.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society